Stiripentol fails to lower plasma oxalate in a dialysis-dependent PH1 patient.

Caroline KempfAnja PfauJohannes HolleKaren Müller-SchlüterPhilip BuflerFelix KnaufDominik Müller

Published in: Pediatric nephrology (Berlin, Germany) (2020)

We conclude that Stiripentol may not be useful to reduce POx in PH patients with advanced chronic kidney disease (CKD), but larger studies are needed to confirm this finding.

Keyphrases

chronic kidney disease
end stage renal disease
case report
peritoneal dialysis
case control